Recently Posted Guidance Documents
Animal and Veterinary
1/4/17: CVM GFI #242 In-Use Stability Studies and Associated Labeling Statements for Multiple-Dose Injectable Animal Drug Products
1/5/17: VICH GL56 - CVM GFI #243 Study Design Recommendations for Residue Studies in Honey for Establishing Maximum Residue Limits and Withdrawal Periods
Biologics
1/3/17: Labeling of Red Blood Cell Units with Historical Antigen Typing Results; Draft Guidance for IndustryDrugs
12/28/16: Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry
12/28/16: Clinical Pharmacology Data to Support a Demonstration of Biosimilarity to a Reference Product
FDA Operations
12/16/16: Gifts to FDA: Evaluation and Acceptance
Food
1/4/17: Questions and Answers on the Nutrition and Supplement Facts Labels Related to the Compliance Date, Added Sugars, and Declaration of Quantitative Amounts of Vitamins and Minerals, Draft Guidance for Industry1/4/17: Reference Amounts Customarily Consumed: List of Products for Each Product Category, Draft Guidance for Industry
Medical Devices
12/27/16: Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions - Guidance for Industry and Food and Drug Administration Staff12/28/16: Postmarket Management of Cybersecurity in Medical Devices - Guidance for Industry and Food and Drug Administration Staff
12/30/16: Medical Device Accessories - Describing Accessories and Classification Pathway for New Accessory Types - Guidance for Industry and Food and Drug Administration Staff
1/3/17: Premarket Notification (510(k)) Submissions for Bone Anchors - Draft Guidance for Industry and Food and Drug Administration Staff
No hay comentarios:
Publicar un comentario